Abstract
Some N-of-1 trials are conducted as part of clinical care, others are developed as research. For those that are research, unless they are deemed exempt from formal review, a relevant Human Research Ethics Committee or Institutional Review Board should review specific projects before they are approved. N-of-1 trials should also be authorized by institutions before commencing. The level of risk to the patient/participant should guide and determine whether a particular project is exempt from review, subject to a low/negligible risk review, or should be reviewed by a full committee. Research ethics reviewers must develop a heightened ethical sensitivity toward ensuring that a misguided approach to N-of-1 review does not occur. Clinical researchers, institutions and research review committees, should recognize the continuum of clinical care and clinical research, in order to set and act from explicit standards which are consistent with the clinical practice – clinical research continuum.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Appelbaum PS, Lidz C, Meisel A (1987) Informed consent. Oxford University Press, New York
Beauchamp T, Childress J (2001) Principles of biomedical ethics. Oxford University Press, New York
Brignardello-Petersen R, Ioannidis JPA, Tomlinson G, Guyatt G (2014) Surprising results of randomized trials. In: Guyatt G, Meade MO, Cook DJ, Rennie D (eds) Users’ guides to the medical literature: a manual for evidence-based clinical practice, 2nd edn. McGraw-Hill, New York
Crowden A (2013) Chapter 6: ethics and indigenous health care: cultural competencies, protocols and integrity. In: Hampton R, Toombs M (eds) Indigenous Australians and health: the wombat in the room. Oxford University Press, South Melbourne, Victoria, Australia, pp 114–129
Evans I, Thornton H, Chalmers I, Glasziou P (2013) Testing treatments: better research for better healthcare, 2nd edn. Pinter &Martin Ltd., London
Faden R, Beauchamp T, King N (1986) A history and theory of informed consent. Oxford University Press, New York
Gabriel SE, Normand SL (2012) Getting the methods right – the foundation of patient-centered outcomes research. N Engl J Med 367(9):787–790
Guyatt G (1996) Clinical care and clinical research: a false dichotomy. In: Daly J (ed) Ethical intersections: health research, methods and researcher responsibility. Allen and Unwin, Sydney, pp 66–73
Guyatt GH, Sackett DL, Taylor DW et al (1986) Determining optimal therapy-randomised trials in individual patients. N Engl J Med 314:889–892
Keech A, Gebski V, Pike R (2007) Interpreting and reporting clinical trials. A guide to the consort statement and the principles of randomised controlled trials. Australian Medical Publishing, Sydney
Kerridge I, Lowe M, Stewart C (2013) Ethics and law for the health professions. The Federation Press, Leichardt
Kottow M (2009) Clinical and research ethics as moral strangers. Arch Immunol Ther Exp (Warsz) 57:157–164
Kravitz R, Duan N (eds) (2014) Design and Implementation of N-of-1 Trials: a user’s guide, Agency for healthcare research and quality, US Department of Health and Human Services, Feb 2014
Lantos J (1994) Ethical issues – how can we distinguish clinical research from innovative therapy? Am J Pediatr Hematol/Oncol 16:72–75
Lewens T (2006) Distinguishing treatment from research: a functional approach. J Med Ethics 32:424–429
Parfitt D (2013) On what matters, vol 1. Oxford University Press, Oxford/New York, p 178
Punja S, Vohra S, Eslick I, Duan N (2014) An ethical framework for N-of-1 trials: clinical care, quality improvement, or human subjects research? In: Kravitz RL, Duan N (eds) Design and implementation of N-of-1 trials: a user’s guide. AHRQ Publication No. 13(14)-EHC122-EF. Rockville, pp 13–22. www.effectivehealthcare.ahrq.gov/N-1-Trials.cfm
Stepanov N (2014) Questioning the boundaries of parental rights: exploring children’s rights, the best interests standard, and parental consent to paediatric non-therapeutic experimental research. Doctor of Philosophy PhD, The University of Melbourne
Stepanov N, Smith MK (2013) Double standards in special medical research: questioning the discrepancy between requirements for medical research involving incompetent adults and medical research involving children. J Law Med 21:47–52
Tate RL, Perdices M, Rosenkoetter U et al (2013) Revision of a method quality rating scale for single-case experimental designs and n-of-1 trials: the 15-item risk of bias in N-of-1 trials (RoBiNT) scale. Neuropsychol Rehabil 23(5):619–638
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Crowden, A., Guyatt, G., Stepanov, N., Vohra, S. (2015). Research Ethics and N-of-1 Trials. In: Nikles, J., Mitchell, G. (eds) The Essential Guide to N-of-1 Trials in Health. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-7200-6_11
Download citation
DOI: https://doi.org/10.1007/978-94-017-7200-6_11
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-017-7199-3
Online ISBN: 978-94-017-7200-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)